These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18065102)

  • 1. In vitro permeation characteristics of moxifloxacin from oil drops through excised goat, sheep, buffalo and rabbit corneas.
    Pawar PK; Majumdar DK
    Pharmazie; 2007 Nov; 62(11):853-7. PubMed ID: 18065102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.
    Pawar PK; Majumdar DK
    AAPS PharmSciTech; 2006 Feb; 7(1):E13. PubMed ID: 16584143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.
    Pawar PK; Majumdar DK
    AAPS PharmSciTech; 2006 Mar; 7(1):E89. PubMed ID: 28290028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro corneal permeation of diclofenac from oil drops.
    Ahuja M; Sharma SK; Majumdar DK
    Yakugaku Zasshi; 2007 Oct; 127(10):1739-45. PubMed ID: 17917432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 1997 Dec; 35(12):1324-30. PubMed ID: 9567769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops.
    Rathore MS; Majumdar DK
    AAPS PharmSciTech; 2006 Jul; 7(3):57. PubMed ID: 17025238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of in vitro transcorneal approach of aceclofenac eye drops through excised goat, sheep, and buffalo corneas.
    Dave V; Paliwal S; Yadav S; Sharma S
    ScientificWorldJournal; 2015; 2015():432376. PubMed ID: 25654129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aceclofenac oil drops: characterization and evaluation against ocular inflammation.
    Katara R; Sachdeva S; Majumdar DK
    Pharm Dev Technol; 2018 Mar; 23(3):240-246. PubMed ID: 28565934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach to formulation factor of aceclofenac eye drops efficiency evaluation based on physicochemical characteristics of in vitro and in vivo permeation.
    Dave V; Paliwal S
    Saudi Pharm J; 2014 Jul; 22(3):240-5. PubMed ID: 25061410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 2002 May; 40(5):555-9. PubMed ID: 12622201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation.
    El-Laithy HM; Nesseem DI; El-Adly AA; Shoukry M
    Arch Pharm Res; 2011 Oct; 34(10):1663-78. PubMed ID: 22076767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of moxifloxacin hydrochloride ocular inserts.
    Pawar PK; Katara R; Majumdar DK
    Acta Pharm; 2012 Mar; 62(1):93-104. PubMed ID: 22472452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of carrier mediated transport of ascorbic acid through mammalian cornea.
    Singla S; Majumdar DK; Goyal S; Khilnani G
    Saudi Pharm J; 2011 Jul; 19(3):165-70. PubMed ID: 23960755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of formulation factors on in-vitro permeation of diclofenac from experimental and marketed aqueous eye drops through excised goat cornea.
    Ahuja M; Dhake AS; Majumdar DK
    Yakugaku Zasshi; 2006 Dec; 126(12):1369-75. PubMed ID: 17139162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
    Hariprasad SM; Shah GK; Chi J; Prince RA
    J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 1997 Sep; 35(9):941-7. PubMed ID: 9475074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcorneal permeation of ciprofloxacin and diclofenac from marketed eye drops.
    Patidar N; Rathore MS; Sharma DK; Middha A; Gupta VB
    Indian J Pharm Sci; 2008 Sep; 70(5):651-4. PubMed ID: 21394267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields.
    Kleinmann G; Larson S; Neuhann IM; Hunold AC; LeBoyer R; Hickman S; Mamalis N; Olson RJ
    Cornea; 2006 Feb; 25(2):209-13. PubMed ID: 16371785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP; Caudle D; Aronowicz JD; Shine WE
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.